These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28464741)

  • 1. Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer.
    Mikalsen LTG; Arnesen MR; Bogsrud TV; Dale E; Stokke C
    Acta Oncol; 2017 Jun; 56(6):894-897. PubMed ID: 28464741
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of dosimetry in the treatment of differentiated thyroid cancer.
    Lassmann M; Hänscheid H; Verburg FA; Luster M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):107-15. PubMed ID: 21386785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary thyroid carcinoma metastasizing to the sphenoid-ethmoid sinuses and skull base.
    Freeman JL; Gershon A; Liavaag PG; Walfish PG
    Thyroid; 1996 Feb; 6(1):59-61. PubMed ID: 8777386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential false-positive posttherapy radioiodine scan secondary to I-131 excretion in perspiration.
    Joyce WT; Cowan RJ
    Clin Nucl Med; 1995 Apr; 20(4):368-9. PubMed ID: 7788999
    [No Abstract]   [Full Text] [Related]  

  • 7. [The basis for radioiodine therapy in differentiated thyroid cancer].
    Haldemann AR
    Ther Umsch; 1999 Jul; 56(7):403-7. PubMed ID: 10434780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radioiodine therapy and percutaneous radiotherapy of struma maligna].
    Kimmig B
    Radiologe; 1989 Mar; 29(3):125-31. PubMed ID: 2652184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial dose mapping for individualizing radioiodine treatment.
    Lassmann M; Hänscheid H
    J Nucl Med; 2007 Jan; 48(1):2-4. PubMed ID: 17204691
    [No Abstract]   [Full Text] [Related]  

  • 12. The beginnings of radioiodine therapy of metastatic thyroid carcinoma: a memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient.
    Siegel E
    Cancer Biother Radiopharm; 1999 Apr; 14(2):71-9. PubMed ID: 10850290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine and radiotherapy in the management of thyroid cancers.
    Simpson WJ
    Otolaryngol Clin North Am; 1990 Jun; 23(3):509-21. PubMed ID: 1694984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.
    Verburg FA; Dietlein M; Lassmann M; Luster M; Reiners C
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):343-6. PubMed ID: 19050874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effective focal doses and the radiation loads in the radioiodine therapy of thyroid cancer].
    Ivanitskaia VI; Shantyr' VI; Pudovkina LF; Kozhukhov VD
    Med Radiol (Mosk); 1981 Nov; 26(11):6-12. PubMed ID: 7332697
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy.
    de Keizer B; Brans B; Hoekstra A; Zelissen PM; Koppeschaar HP; Lips CJ; van Rijk PP; Dierckx RA; de Klerk JM
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):367-73. PubMed ID: 12634964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postoperative external radiotherapy of differentiated thyroid carcinoma: when is radioiodine therapy alone inadequate? The dosimetric considerations with a Monte Carlo simulation].
    Sautter-Bihl ML; Herbold G; Heinze HG; Bihl H
    Strahlenther Onkol; 1991 May; 167(5):267-72. PubMed ID: 2038708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic response of follicular thyroid carcinoma with superior vena cava syndrome and tracheal obstruction to external-beam radiotherapy.
    Wilford MR; Chertow BS; Lepanto PB; Leidy JW
    Am J Med; 1991 Jun; 90(6):753-7. PubMed ID: 2042692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioiodine therapy for lung and bone metastasis of differentiated thyroid cancer].
    Inagaki T; Shibata T; Iida Y; Kasagi K; Endo K; Konishi J; Torizuka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Mar; 45(3):518-24. PubMed ID: 4011426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.